ISPAD Clinical Practice Consensus Guidelines 2022: Nutritional management in children and adolescents with diabetes.

IF 3.9 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Pediatric Diabetes Pub Date : 2022-12-01 DOI:10.1111/pedi.13429

S Francesca Annan, Laurie A Higgins, Elisabeth Jelleryd, Tamara Hannon, Shelley Rose, Sheryl Salis, Juliana Baptista, Paula Chinchilla, Maria Loredana Marcovecchio

引用次数: 20

Abstract

Paediatric Division, University College London Hospitals, London, UK Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Boston, Massachusetts, USA Medical Unit Clinical Nutrition, Karolinska University Hospital, Stockholm, Sweden School of Medicine, Indiana University, Indianapolis, Indiana, USA Diabetes & Endocrinology Service, MidCentral District Health Board, Palmerston North, New Zealand Department of Nutrition, Nurture Health Solutions, Mumbai, India Diabetes Training and Education, Medtronic, Sao Paulo, Brazil Women's and Children's Department, London North West Healthcare NHS Trust, London, UK Department of Paediatrics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

查看原文本刊更多论文

ISPAD临床实践共识指南2022:糖尿病儿童和青少年的营养管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Diabetes 医学-内分泌学与代谢

CiteScore

6.60

自引率

14.70%

发文量

141

审稿时长

4-8 weeks

期刊介绍： Pediatric Diabetes is a bi-monthly journal devoted to disseminating new knowledge relating to the epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes in childhood and adolescence. The aim of the journal is to become the leading vehicle for international dissemination of research and practice relating to diabetes in youth. Papers are considered for publication based on the rigor of scientific approach, novelty, and importance for understanding mechanisms involved in the epidemiology and etiology of this disease, especially its molecular, biochemical and physiological aspects. Work relating to the clinical presentation, course, management and outcome of diabetes, including its physical and emotional sequelae, is considered. In vitro studies using animal or human tissues, whole animal and clinical studies in humans are also considered. The journal reviews full-length papers, preliminary communications with important new information, clinical reports, and reviews of major topics. Invited editorials, commentaries, and perspectives are a regular feature. The editors, based in the USA, Europe, and Australasia, maintain regular communications to assure rapid turnaround time of submitted manuscripts.